ArticleBlood advances2018

Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas.

Erin G Reid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.